These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30311164)

  • 1. Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?
    Perez MC; Oliver DE; Weitman ES; Boulware D; Messina JL; Torres-Roca J; Cruse CW; Gonzalez RJ; Sarnaik AA; Sondak VK; Wuthrick EJ; Harrison LB; Zager JS
    Ann Surg Oncol; 2019 Feb; 26(2):379-385. PubMed ID: 30311164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma.
    Lee JS; Durham AB; Bichakjian CK; Harms PW; Hayman JA; McLean SA; Harms KL; Burns WR
    Ann Surg Oncol; 2019 Feb; 26(2):386-394. PubMed ID: 30556118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completion lymph node dissection for merkel cell carcinoma.
    Cramer JD; Suresh K; Sridharan S
    Am J Surg; 2020 Oct; 220(4):982-986. PubMed ID: 32087988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature.
    Gupta SG; Wang LC; Peñas PF; Gellenthin M; Lee SJ; Nghiem P
    Arch Dermatol; 2006 Jun; 142(6):685-90. PubMed ID: 16785370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients.
    Sims JR; Grotz TE; Pockaj BA; Joseph RW; Foote RL; Otley CC; Weaver AL; Jakub JW; Price DL
    Surg Oncol; 2018 Mar; 27(1):11-17. PubMed ID: 29549898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
    Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Kraus DH; Brady MS; Coit DG
    Ann Surg Oncol; 2011 Sep; 18(9):2529-37. PubMed ID: 21431988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma: 30-year experience from a single institution.
    Santamaria-Barria JA; Boland GM; Yeap BY; Nardi V; Dias-Santagata D; Cusack JC
    Ann Surg Oncol; 2013 Apr; 20(4):1365-73. PubMed ID: 23208132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis.
    Stokes JB; Graw KS; Dengel LT; Swenson BR; Bauer TW; Slingluff CL; Ledesma EJ
    J Clin Oncol; 2009 Aug; 27(23):3772-7. PubMed ID: 19581538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in clinically node-negative Merkel cell carcinoma: the Westmead Hospital experience.
    Jenkins LN; Howle JR; Veness MJ
    ANZ J Surg; 2019 May; 89(5):520-523. PubMed ID: 30959572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma.
    Fang LC; Lemos B; Douglas J; Iyer J; Nghiem P
    Cancer; 2010 Apr; 116(7):1783-90. PubMed ID: 20162707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences.
    Grotz TE; Joseph RW; Pockaj BA; Foote RL; Otley CC; Bagaria SP; Weaver AL; Jakub JW
    Ann Surg Oncol; 2015 Nov; 22(12):4060-6. PubMed ID: 25676844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.
    Ma KL; Sharon CE; Tortorello GN; Perry NJ; Keele LJ; Lukens JN; Karakousis GC; Miura JT
    Ann Surg Oncol; 2023 Jul; 30(7):4345-4355. PubMed ID: 37106277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
    Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
    Servy A; Maubec E; Sugier PE; Grange F; Mansard S; Lesimple T; Marinho E; Couturaud B; Girod A; Albert S; Dendale R; Calitchi E; Sarda L; Chanal J; Deschamps L; Sastre-Garau X; Laroche L; Crickx B; Avril MF
    Ann Oncol; 2016 May; 27(5):914-9. PubMed ID: 26811346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Uppal A; Stern S; Thompson JF; Foshag L; Mizzollo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Kashani-Sabet M; Coventry BJ; Cochran AJ; Fujita M; Sim-Shin M; Elashoff D; Elashoff RM; Faries MB
    Ann Surg Oncol; 2020 Jun; 27(6):1970-1977. PubMed ID: 31863416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
    Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.